BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24615476)

  • 21. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
    Santini D; Vincenzi B; Fratto ME; Perrone G; Lai R; Catalano V; Cass C; Ruffini PA; Spoto C; Muretto P; Rizzo S; Muda AO; Mackey JR; Russo A; Tonini G; Graziano F
    J Cell Physiol; 2010 May; 223(2):384-8. PubMed ID: 20082300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
    Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
    J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fascin expression is related to poor survival in gastric cancer.
    Kim SJ; Kim DC; Kim MC; Jung GJ; Kim KH; Jang JS; Kwon HC; Kim YM; Jeong JS
    Pathol Int; 2012 Dec; 62(12):777-84. PubMed ID: 23252866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
    Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
    Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of βIII-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer.
    Zheng WE; Chen H; Yuan SF; Wu LL; Zhang W; Sun HY; Chen WJ
    J BUON; 2012; 17(2):284-90. PubMed ID: 22740207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays.
    Kim KC; Koh YW; Chang HM; Kim TH; Yook JH; Kim BS; Jang SJ; Park YS
    Ann Surg Oncol; 2011 Oct; 18(10):2833-40. PubMed ID: 21468783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammalian target of rapamycin expression and laryngeal squamous cell carcinoma prognosis: novel preliminary evidence.
    Marioni G; Staffieri A; Giacomelli L; Lionello M; Guzzardo V; Busnardo A; Blandamura S
    Histopathology; 2011 Jun; 58(7):1148-56. PubMed ID: 21707714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.
    Bai J; Zhou Y; Chen G; Zeng J; Ding J; Tan Y; Zhou J; Li G
    Hum Pathol; 2011 Mar; 42(3):375-83. PubMed ID: 21190721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
    Boltze C
    Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of SIRT1 in gastric cardiac cancer and its clinicopathologic significance.
    Feng AN; Zhang LH; Fan XS; Huang Q; Ye Q; Wu HY; Yang J
    Int J Surg Pathol; 2011 Dec; 19(6):743-50. PubMed ID: 21865267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.
    Gamboa-Dominguez A; Seidl S; Reyes-Gutierrez E; Hermannstädter C; Quintanilla-Martinez L; Busch R; Höfler H; Fend F; Luber B
    J Clin Pathol; 2007 Jul; 60(7):756-61. PubMed ID: 17483253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma.
    Ohtani M; Isozaki H; Fujii K; Nomura E; Niki M; Mabuchi H; Nishiguchi K; Toyoda M; Ishibashi T; Tanigawa N
    Cancer; 1999 Apr; 85(8):1711-8. PubMed ID: 10223564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
    Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
    Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma.
    Liu D; Huang Y; Chen B; Zeng J; Guo N; Zhang S; Liu L; Xu H; Mo X; Li W
    Cancer; 2011 Aug; 117(16):3763-73. PubMed ID: 21387259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between LAT1 expression and response to platinum-based chemotherapy in non-small cell lung cancer patients with postoperative recurrence.
    Kaira K; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Oriuchi N; Kanai Y; Endo M; Kondo H; Nakajima T; Yamamoto N
    Anticancer Res; 2011 Nov; 31(11):3775-82. PubMed ID: 22110199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer.
    Yu G; Wang J; Chen Y; Wang X; Pan J; Li G; Jia Z; Li Q; Yao JC; Xie K
    Clin Cancer Res; 2009 Mar; 15(5):1821-9. PubMed ID: 19223493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.